Dr. Lindor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
13400 E Shea Blvd
Scottsdale, AZ 85259Phone+1 602-496-0789- Is this information wrong?
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 1983 - 1986
Wake Forest University School of MedicineResidency, Internal Medicine, 1979 - 1982- Mayo Clinic College of MedicineClass of 1979
Certifications & Licensure
MN State Medical License 1983 - 2024
AZ State Medical License 1990 - 2021
NC State Medical License 1979 - 2002- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Fellow (AGAF) American Gastroenterological Association, 2007
- Fellow (FACG) American College of Gastroenterology
Clinical Trials
- Study of Combivir for Patients With Primary Biliary Cirrhosis Start of enrollment: 2004 Jan 01
- Effects of Alanine in Patients With Nonalcoholic Steatohepatitis Start of enrollment: 2004 Feb 01
- Betaine in Patients With Nonalcoholic Steatohepatitis Start of enrollment: 2003 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsSerum miRNA profiles are altered in patients with primary sclerosing cholangitis receiving high-dose ursodeoxycholic acid.Jessica T Hochberg, Aalam Sohal, Priya Handa, Bryan D Maliken, Take-Kyun Kim, Kai Wang, Eric Gochanour, Yu Li, J Bart Rose, James E Nelson, Keith D Lindor, Nicholas F ...> ;JHEP Reports. 2023 Jun 1
- 1 citationsLetter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis.Ahmad H Ali, Cynthia W Buness, Ryan Fischer, Gerald J Holtmann, Ayesha Shah, Peter Lewindon, Shamita Shah, Amol S Ragnekar, Amy E Taylor, Aparna Goel, Kenneth L Cox, L...> ;Hepatology. 2023 Jun 1
- 2 citationsUrsodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis.Rozanne C de Veer, Maria C van Hooff, Christophe Corpechot, Douglas Thorburn, Pietro Invernizzi, Willem J Lammers, Harry L A Janssen, Pier M Battezzati, Frederik Neven...> ;The American Journal of Gastroenterology. 2023 Jul 1
- Join now to see all
Press Mentions
Immunic, Inc. Announces Positive Top-Line Data from Investigator-Sponsored Phase 2 Proof-of-Concept Clinical Trial of IMU-838 in Primary Sclerosing CholangitisFebruary 18th, 2021
Immunic, Inc. Announces First Patient Enrolled in Investigator-Sponsored Proof-of-Concept Clinical Trial of IMU-838 for the Treatment of Patients with Primary Sclerosing CholangitisFebruary 11th, 2020
Mayo Clinic & ASU Investigator-Initiated Study Focusing on Investigational Product for Primary Sclerosing CholangitisAugust 14th, 2019- Join now to see all
Grant Support
- Multicentered Randomized Trial Of High-Dose Urso In PSCNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
- Multicentered Randomized Trail Of High-Dose Urso In PSCNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2006
- Multicentered Randomized Trail Of High-Dose Urso In PSCNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2003
- Multicentered Randomized Trial Of High-Dose Urso In PSCNational Institute Of Diabetes And Digestive And Kidney Diseases2001
- Pilot Study Of Pirfenidone In PBC And PSCNational Institute Of Diabetes And Digestive And Kidney Diseases1998–1999
- Pilot Study Of Budesonide For Patients With PSC And PBCNational Institute Of Diabetes And Digestive And Kidney Diseases1997–1998
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
